Genmab — November 2017

[E_L]

think we got something

[sowise]

nigen=noget

[sowise]

nogen

[StockBull]

Kursen kryber opad

[JohnW]

Ok. Jeg kan ikke bedømme ud fra linket.

[E_L]

on twitter i see this
JOHNSON & JOHNSON'S DARZALEX PLUS STANDARD DRUGS CUTS MULTIPLE MYELOMA PROGRESSION RISK 50 PCT VS STANDARD REGIMEN-STUDY #GEN

[E_L]

could be spam

[jkj]

ORR 90,9

[sowise]

?

[E_L]

reuters https://www.reuters.com/article/health-johnsonjohnson-myeloma/jj-multiple-myeloma-drug-succeeds-in-first-line-combination-study-idUSL1N1NQ1TK

[JKY_VH]

Tak E L , bibob og jkj

[GeorgeBest]

Thanks E L

[jkj]

ikke late breaker såvidt jeg kan se ,
præsenteres på næste ash møde om 1 måned ifølge reuters

[jkj]

eller hva ?

[gentogen]

Tak for link. Ser solidt ud.

[gentogen]

The rate of complete responses, meaning no detectable cancer in the blood or bone marrow, was 42.6 percent for Darzalex versus 24.4 percent for the standard regimen.

[rex_pacis]

thanks @e

[sowise]

en kurs
belønning kom der ikke ud af det

[Bulder]

Det er lavere CR end Pollux i 2. linje

[OHW]

Data er ikke interessante nok til at løfte kursen..